<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA Dermatology: Radiography Topic Collection</title>
    <link>http://archderm.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Mon, 10 Dec 2012 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 01 Jan 2013 00:51:34 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@archderm.jamanetwork.com</managingEditor>
    <webMaster>webmaster@archderm.jamanetwork.com</webMaster>
    <item>
      <title>Integrated Positron-Emission Tomography and Computed Tomography Manifestations of Cutaneous T-Cell Lymphoma</title>
      <link>http://archderm.jamanetwork.com/article.aspx?articleID=1485960</link>
      <pubDate>Sat, 01 Dec 2012 00:00:00 GMT</pubDate>
      <author>Kamstrup MR, Gniadecki R, Friberg L. </author>
      <description>&lt;span class="paragraphSection"&gt;Mycosis fungoides (MF) and Sézary syndrome (SS) represent the most common types of primary cutaneous T-cell lymphomas (CTCLs). Current guidelines recommend [18F]-fluorodeoxyglucose positron-emission tomography (FDG-PET) plus computed tomography (CT) scan for staging purposes in all patients except in cases of early-stage disease (IA-IB). However, the application of FDG-PET in CTCL has not been widely documented. In this study, we retrospectively evaluated the findings of FDG-PET/CT scans in 41 patients with CTCL.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">148</prism:volume>
      <prism:number xmlns:prism="prism">12</prism:number>
      <prism:startingPage xmlns:prism="prism">1420</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">1422</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/archdermatol.2012.3198</prism:doi>
      <guid>http://archderm.jamanetwork.com/article.aspx?articleID=1485960</guid>
    </item>
  </channel>
</rss>